SRTS logo

SRTS
Sensus Healthcare Inc

1,165
Mkt Cap
$57.12M
Volume
23,439.00
52W High
$5.92
52W Low
$2.82
PE Ratio
-7.06
SRTS Fundamentals
Price
$3.35
Prev Close
$3.47
Open
$3.46
50D MA
$3.99
Beta
0.84
Avg. Volume
35,472.74
EPS (Annual)
-$0.4728
P/B
1.21
Rev/Employee
$458,033.33
$43.37
Loading...
Loading...
News
all
press releases
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026. Highlights...
Business Wire·13d ago
News Placeholder
More News
News Placeholder
Sensus Healthcare (SRTS) Projected to Post Earnings on Thursday
Sensus Healthcare (NASDAQ:SRTS) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...
MarketBeat·20d ago
News Placeholder
Sensus Healthcare (NASDAQ:SRTS) Shares Pass Below 50-Day Moving Average - Here's Why
Sensus Healthcare (NASDAQ:SRTS) Stock Passes Below Fifty Day Moving Average - Time to Sell...
MarketBeat·20d ago
News Placeholder
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced...
Business Wire·27d ago
News Placeholder
Sensus Healthcare, Inc. (NASDAQ:SRTS) Receives Average Rating of "Moderate Buy" from Analysts
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned...
MarketBeat·29d ago
News Placeholder
Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) saw a large decrease in short interest in March. As of March 13th, there was short interest totaling 394,950 shares, a decrease of 18.3% from the February 26th total of 483,655 shares. Currently, 2.6% of the company's shares are sold short...
MarketBeat·2mo ago
News Placeholder
Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) have been given an average rating of "Moderate Buy" by the six analysts that are currently covering the firm, MarketBeat.com reports...
MarketBeat·2mo ago
News Placeholder
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the filing of a lawsuit in the Circuit Court for the Fifteenth...
Business Wire·2mo ago
News Placeholder
Sensus Healthcare (NASDAQ:SRTS) Now Covered by Analysts at Alliance Global Partners
Alliance Global Partners started coverage on Sensus Healthcare in a research report on Friday. They set a "buy" rating and a $7.50 price target for the company...
MarketBeat·2mo ago
News Placeholder
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100 Installed Base
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·3mo ago
<
1
2
...
>

Latest SRTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.